Journals / Van Veterinary Journal / 2013 / Cilt: 24 - Sayı: 2

Deneysel Olarak Diyabet Oluşturulmuş Sıçanlarda Hba1c,Mda,Gsh-Px ve Sod Miktarlarının Tayini

Pages
51–54
Publication Date
2013-06-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As conclusion, HbA1c was important parameters for the diagnosis at Diabetes mellitus, antioxidant enzyme activity changes could be important for the prognosis of Diabetes mellitus and clinicians must be careful and take in consideration of these changes during the treatment of their diabetic patient.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diabetes Mellitus is the results of deficiency of insulin secretion and effect was studied on Wistar rats in this research.
📊
Key Findings & Data:Rats were randomly divided into 2 groups, 10 rats were healthy control and 20 rats were sick group.
💡
Conclusion & Impact:As conclusion, HbA1c was important parameters for the diagnosis at Diabetes mellitus, antioxidant enzyme activity changes could be important for the prognosis of Diabetes mellitus and clinicians must be careful and take in consideration of these changes during the treatment of their diabetic patient.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Diabetes Mellitus · Hemoglobin A1c · Glutatyon peroksidaz

Abstract

Diabetes Mellitus is the results of deficiency of insulin secretion and effect was studied on Wistar rats in this research. Rats were randomly divided into 2 groups, 10 rats were healthy control and 20 rats were sick group. To develop experimental diabetes 45 mg/kg streptozotocine was administrated intraperiteonally to 20 rats in sick group. HbA1c, MDA, GSH-Px and SOD analysis were performed to blood samples of all rats. The levels HbA1c were increased significantly P0.05). GSH-Px activity was significantly decreased in sick group, SOD activity was increased but statistical significance was not detected (P≤0.05). As conclusion, HbA1c was important parameters for the diagnosis at Diabetes mellitus, antioxidant enzyme activity changes could be important for the prognosis of Diabetes mellitus and clinicians must be careful and take in consideration of these changes during the treatment of their diabetic patient.

Özet

İnsülin sekresyonu veya etkisinde yetmezliği ile karakterize olan ve günümüzde çok yaygın olan Diabetes Mellitus üzerinde yapılan bu çalışmada 7-8 haftalık Wistar cinsi sıçanlar kullanıldı. Rastgele seçilen 10 sıçan kontrol, 20 sıçan diyabetli grup olmak üzere 2 grup oluşturuldu. Diyabetli gruba 45 mg/kg düzeyinde streptozotosin intraperitoneal uygulandı. Tüm hayvanlarda HbA1c, MDA, GSH-Px ve SOD düzeylerine bakıldı. HbA1c diyabetli grupta P0.05). GSH-Px düzeyi diyabetli grupta azalmış (P

🔖

Cite This Article

YEGİN, S. Ç., MERT, N. (2013). Deneysel Olarak Diyabet Oluşturulmuş Sıçanlarda Hba1c,Mda,Gsh-Px ve Sod Miktarlarının Tayini. Van Veterinary Journal, Cilt: 24 - Sayı: 2, 51–54. https://ajindex.com/articles/32742

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Abou-Seif MA, Youssef AA (2004). Evaulation of some biochemical changes in diabetic patients. Clin Chim Acta, 346 (2), 161-70.
  2. Abou-Seif MAM, Youssef H (2001). Oxidative stress and male IGF-1, gonadotropin and related hormones in diabetic patients. Clin Chem Lab Med, 39(7), 618-623.
  3. Aliakber S, Brown PR and Bidwell DE (1993). Human erythrocyte superoxide dismutase in adults, neonates and chromosomally abnormal fetuses. Clin Biochem, 26, 109–113.
  4. Aslan R, Şekeroğlu MR, Bayiroğlu F (1995). Serbest radikal türlerin membran lipid peroksidasyonuna etkileri ve hücresel antioksidan savunma. Sağ Bil Derg, 2, 137-142.
  5. Bekerecioğlu M, Uğraş S, Dilek ON (1998). Serbest Radikaller. Sendrom, 10 (3), 85–94.
  6. Braunwald ER, Fauci A, Kasper D, Hauser SL, Longo DL, Jameson JL (2003). Harrison’s Principles of İnternal Medicine. 12th Ed., McGraw- Hill, p: 2019-2025,
  7. New York. Bunn HF (1981). Nonenzimatic glycosylation of protein, relevance of diabetes. Am J Med, 70, 325-330.
  8. Carl A, Burtis R, Edward R, Ashwood MD (2003). Tietz Textbook of Clinical Chemistry. 3rd Ed., WB Saunders, p:790-796,
  9. Philadelphia. Cengiz M, Cengiz S (2000). Tip II diyabetli hastalarda C vitamini uygulamasının eritrosit glutatyon ve HbA1c düzeyleri üzerine etkisi. Cerrahpaşa Tıp Derg I, 31(4), 211-215.
  10. Cheeseman KH, Slater TF (1993). An introduction to free radical biochemistry. Br Med Bull, 49(3), 481-493.
  11. Fairbanks VF, Klee GG (1994) Biochemical Aspects of Hematology. Second edition, WB Saunders Company, p:1974-2072,
  12. Philadephia. Flohe L, Gunzler WA (1984). Assays of glutathione peroxidase, in: Methods in Enzymology, L Packer (ed), 105: p:114-115,
  13. New York. Flohe L, Otting F (1984). Superoxide dismutase assays, in: Methods in Enzymology, Packer L (ed), 105: 93-104,
  14. New York. Gutteridge JM (1995). Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem, 41:(12), 1819-1828.
  15. Güzel S, Seven A, Civelek S, Salman S, Satman İ, Burçak G (2001). Tip I diyabetiklerin erken ve geç döneminde antioksidan statü. Cerrahpaşa Tıp Derg, 32 (4), 243-248.
  16. Halifeoğlu İ, Karataş F, Çolak R, Canatan H, Telo S (2005). Tip II diyabetik hastalarda tedavi öncesi ve tedavi sonrası oksidant ve antioksidant I. Fırat Tıp Dergisi, Cilt 10, Sayı 3, 117-122.
  17. Jacob RA, Burr BJ (1996). Oxidative damage and defence. Am J Clin Nut, 63, 985-990.
  18. Kaneto H, Kajimoto Y, Miyagawa J, Matsuoka T, Fujitani Y, Umayahara Y, Hanafusa T, Matsuzawa Y, Yamasaki Y, Hori M (1999). Beneficial effects of antioksidant in diabetes, possi